CN105431202B - 骨移植物成骨潜能的增强 - Google Patents

骨移植物成骨潜能的增强 Download PDF

Info

Publication number
CN105431202B
CN105431202B CN201480040557.6A CN201480040557A CN105431202B CN 105431202 B CN105431202 B CN 105431202B CN 201480040557 A CN201480040557 A CN 201480040557A CN 105431202 B CN105431202 B CN 105431202B
Authority
CN
China
Prior art keywords
cells
bone graft
graft material
wnt
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201480040557.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN105431202A (zh
Inventor
G·达姆德赫瑞
J·赫尔姆斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Priority to CN202010166831.1A priority Critical patent/CN111643733B/zh
Publication of CN105431202A publication Critical patent/CN105431202A/zh
Application granted granted Critical
Publication of CN105431202B publication Critical patent/CN105431202B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645—Connective tissue
    • A61L27/365—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Botany (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
CN201480040557.6A 2013-07-16 2014-07-16 骨移植物成骨潜能的增强 Expired - Fee Related CN105431202B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010166831.1A CN111643733B (zh) 2013-07-16 2014-07-16 骨移植物成骨潜能的增强

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361957946P 2013-07-16 2013-07-16
US61/957,946 2013-07-16
PCT/US2014/046852 WO2015009829A2 (en) 2013-07-16 2014-07-16 Enhancement of osteogenic potential of bone grafts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN202010166831.1A Division CN111643733B (zh) 2013-07-16 2014-07-16 骨移植物成骨潜能的增强

Publications (2)

Publication Number Publication Date
CN105431202A CN105431202A (zh) 2016-03-23
CN105431202B true CN105431202B (zh) 2020-03-24

Family

ID=52346837

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201480040557.6A Expired - Fee Related CN105431202B (zh) 2013-07-16 2014-07-16 骨移植物成骨潜能的增强
CN202010166831.1A Expired - Fee Related CN111643733B (zh) 2013-07-16 2014-07-16 骨移植物成骨潜能的增强

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN202010166831.1A Expired - Fee Related CN111643733B (zh) 2013-07-16 2014-07-16 骨移植物成骨潜能的增强

Country Status (12)

Country Link
US (4) US9301980B2 (https=)
EP (1) EP3021943B1 (https=)
JP (2) JP6557659B2 (https=)
KR (1) KR102307174B1 (https=)
CN (2) CN105431202B (https=)
AU (2) AU2014290042B2 (https=)
CA (1) CA2916898A1 (https=)
GB (2) GB2530224B (https=)
IL (1) IL243288B (https=)
MX (1) MX2016000464A (https=)
WO (1) WO2015009829A2 (https=)
ZA (1) ZA201600095B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3328453B1 (en) 2015-07-31 2021-03-24 DePuy Synthes Products, Inc. Method of preparing an osteogenic bone graft
US11491262B2 (en) * 2018-04-19 2022-11-08 Paulo Jose PASQUALI Method of bone regeneration
US20210079079A1 (en) * 2018-05-02 2021-03-18 Ortheus, Inc. Systems and methods for local modulation of wnt signaling
CN111700881B (zh) * 2020-07-02 2021-05-18 四川大学 Wnt蛋白＼ZIF-8纳米复合体、其制备方法及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1846793A (zh) * 2005-04-14 2006-10-18 南方医院 一种组织工程骨及其构建与应用
US20100247494A1 (en) * 2009-03-23 2010-09-30 The Texas A&M University System Compositions of Mesenchymal Stem Cells to Regenerate Bone

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545412A (en) 1985-01-07 1996-08-13 Syntex (U.S.A.) Inc. N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
US5705655A (en) 1992-12-17 1998-01-06 Megabios Corporation Amphiphilic nitrogen containing imidazolinium derivative compounds and uses
EP0730405A4 (en) 1993-11-24 1997-02-19 Megabios Corp AMPHIPHILE GUANIDINE DERIVATIVES
NZ277614A (en) 1993-11-24 1998-05-27 Megabios Corp Piperazine-containing amphiphiles and their use in liposomes for delivering genetic material intracellularly
AU696881B2 (en) 1994-06-22 1998-09-24 Megabios Corporation Cationic amphiphiles
DE19521412A1 (de) 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
AU2001295010A1 (en) * 2000-08-18 2002-03-04 Case Western Reserve University Regulator gene and system useful for the diagnosis and therapy of osteoporosis
US6723131B2 (en) * 2001-02-28 2004-04-20 The Cleveland Clinic Foundation Composite bone marrow graft material with method and kit
EP1660663A4 (en) * 2003-08-12 2007-07-11 Brigham & Womens Hospital METHOD AND COMPOSITIONS FOR TISSUE REPAIR
US8343922B2 (en) * 2004-05-19 2013-01-01 Enzo Biochem, Inc. Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
WO2008109119A2 (en) * 2007-03-05 2008-09-12 The Board Of Trustees Of The Leland Stanford Junior University Wnt compositions and methods of use thereof
WO2009073186A1 (en) 2007-12-03 2009-06-11 The Regents Of The University Of California Oxsterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
JP5458238B2 (ja) * 2007-11-30 2014-04-02 一郎 小野 臓器再生用デバイス
CA2734446C (en) * 2008-08-22 2017-06-20 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
WO2012034070A1 (en) * 2010-09-09 2012-03-15 The Board Of Trustees Of The Leland Stanford Junior University Use of liposomal wnt compositions to enhance osseointegration
WO2012135176A2 (en) * 2011-03-28 2012-10-04 The Board Of Trustees Of The Leland Stanford Junior University The use of wnt agents to prevent hypoxic injury

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1846793A (zh) * 2005-04-14 2006-10-18 南方医院 一种组织工程骨及其构建与应用
US20100247494A1 (en) * 2009-03-23 2010-09-30 The Texas A&M University System Compositions of Mesenchymal Stem Cells to Regenerate Bone

Also Published As

Publication number Publication date
KR102307174B1 (ko) 2021-10-01
MX2016000464A (es) 2016-04-07
JP6557659B2 (ja) 2019-08-07
AU2019222935A1 (en) 2019-09-19
JP6897996B2 (ja) 2021-07-07
IL243288A0 (en) 2016-02-29
AU2019222935B2 (en) 2021-09-09
AU2014290042B2 (en) 2019-06-20
KR20160032125A (ko) 2016-03-23
GB2578557A (en) 2020-05-13
WO2015009829A2 (en) 2015-01-22
WO2015009829A3 (en) 2015-11-12
CN111643733A (zh) 2020-09-11
US9301980B2 (en) 2016-04-05
EP3021943B1 (en) 2023-09-13
EP3021943A2 (en) 2016-05-25
CN105431202A (zh) 2016-03-23
GB202001056D0 (en) 2020-03-11
GB201600149D0 (en) 2016-02-17
US20170056556A1 (en) 2017-03-02
GB2578557B (en) 2020-09-02
US20150050249A1 (en) 2015-02-19
US9925304B2 (en) 2018-03-27
US10568989B2 (en) 2020-02-25
CA2916898A1 (en) 2015-01-22
IL243288B (en) 2021-01-31
JP2019177224A (ja) 2019-10-17
US11771803B2 (en) 2023-10-03
JP2016524989A (ja) 2016-08-22
GB2530224B (en) 2020-08-05
US20200147267A1 (en) 2020-05-14
GB2530224A (en) 2016-03-16
US20180140743A1 (en) 2018-05-24
EP3021943A4 (en) 2017-02-15
ZA201600095B (en) 2021-09-29
CN111643733B (zh) 2023-07-28
AU2014290042A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
RU2542430C2 (ru) Многомерный биоматериал и способ его приготовления
Leucht et al. Wnt3a reestablishes osteogenic capacity to bone grafts from aged animals
Jing et al. Reengineering autologous bone grafts with the stem cell activator WNT3A
US11771803B2 (en) Enhancement of osteogenic potential of bone grafts
CN109666629A (zh) 人多能干细胞来源的外泌体、基于该外泌体的制剂及用途
Xing et al. Establishment of a bilateral femoral large segmental bone defect mouse model potentially applicable to basic research in bone tissue engineering
JP7273418B2 (ja) 脂肪由来幹細胞を含む無足場構造物用生体材料およびその作製方法
Mahon et al. Extracellular matrix scaffolds derived from different musculoskeletal tissues drive distinct macrophage phenotypes and direct tissue-specific cellular differentiation
Zhang et al. Osteogenic differentiation of 3D-printed porous tantalum with nano-topographic modification for repairing craniofacial bone defects
CN117545507A (zh) 生化激活功能障碍骨骼干细胞以实现骨骼再生
Shi Systemic Therapy of Inactivated-Bisphosphonate-Conjugated PEGylated NELL-1 (BP-NELL-PEG) for Spaceflight-Induced Osteoporosis
WO2025259915A1 (en) Use of matrix bound nanovesicles (mbv) for inhibition of osteoclasts
Lewis Characterising the therapeutic potential of PEPITEMin age-related bone loss, skeletal remodelling and repair
Baral Osseointegration of a Cementless Total Knee Arthroplasty in a Murine Model of Glucocorticoid Induced Osteoporosis
JP2023512582A (ja) 組織再生パッチ
Wang TLR4-mediated calvarial bone repair: investigating its role and potential use for regenerative medicine
Ramnaraign Endothelial Progenitor Cell Therapy for Fracture Healing in a Rat Femoral Defect Model: A Dose-Response Study
HK40029239B (zh) 非人动物胎儿组织提取物、生产提取物的方法及其用途
Gasser Osteoporosis: Limitations of current antiresorptive treatments

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20200324